Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin
about
Tobramycin nephrotoxicity. A prospective clinical studyAttenuation of experimental tobramycin nephrotoxicity by ticarcillinPotential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsCarbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremiaSynergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids.Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis.Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.Combinations of beta lactam antibiotics.Serum creatinine levels during cardiac surgery: absence of effect by aminoglycosides.First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae
P2860
Q28328829-5406B587-3A5F-408E-BC2F-73C033788A7EQ28362582-3FFF2527-2CC1-4156-9EFE-A017236345E5Q33731809-BC609412-6166-4147-B246-BA0FC0F25221Q33733238-47C9C427-F955-4E6B-BB99-AAFE45EB98CFQ34982841-4C2327C3-17D6-41E7-95CD-81ABFF0F35DCQ34988087-67955170-8FD3-42C4-B4E1-2C5A782CCD11Q35571259-CADD235D-6C0D-4AD7-8FE8-59019296AD75Q36463439-DAC17648-4CB5-4A37-BCC2-404FFC6C677FQ39611982-713FBB25-F573-4F17-9227-9D5722CC2D4AQ40281715-ACEA6B82-B7A5-4695-92B1-B048C0086B7FQ40864054-0EDE4245-C864-4BEE-AAF6-19A4BA63E0D2Q40877633-33265F9E-72BB-48A9-B40E-DCFC9CAFA461Q41707283-3A149154-4DE8-4596-89AA-1530626DFC83Q42225157-4CD088F0-F33C-4767-90F2-864BF0DC5DEDQ43048864-F5980FD6-38B6-405D-A19F-A2868AAA210FQ46512722-D6B9B311-3260-4B40-B9B9-680E50F33EDAQ57240386-0BFD701E-86B0-460D-A15F-3C7FA52E946F
P2860
Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin
description
1975 nî lūn-bûn
@nan
1975 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@ast
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@en
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@nl
type
label
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@ast
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@en
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@nl
prefLabel
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@ast
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@en
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@nl
P2093
P2860
P356
P1476
Empiric therapy for cancer pat ...... in, and cephalothin-tobramycin
@en
P2093
Debusscher L
Hensgens C
Klastersky J
P2860
P304
P356
10.1128/AAC.7.5.640
P407
P577
1975-05-01T00:00:00Z